Andreas Wernitznig

1.7k total citations
26 papers, 1.2k citations indexed

About

Andreas Wernitznig is a scholar working on Molecular Biology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Andreas Wernitznig has authored 26 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 9 papers in Oncology and 5 papers in Pathology and Forensic Medicine. Recurrent topics in Andreas Wernitznig's work include Genetic factors in colorectal cancer (5 papers), Cancer Cells and Metastasis (4 papers) and Cancer-related Molecular Pathways (4 papers). Andreas Wernitznig is often cited by papers focused on Genetic factors in colorectal cancer (5 papers), Cancer Cells and Metastasis (4 papers) and Cancer-related Molecular Pathways (4 papers). Andreas Wernitznig collaborates with scholars based in Austria, Germany and United States. Andreas Wernitznig's co-authors include Wolfgang Sommergruber, Norbert Schweifer, Hartmut Beug, Aneesa Sultan, Thomas Brabletz, Brigitta Dampier, Roland Foisner, Andreas Eger, Wolfgang Mikulits and Martin Schreiber and has published in prestigious journals such as Bioinformatics, PLoS ONE and Cancer Research.

In The Last Decade

Andreas Wernitznig

24 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Andreas Wernitznig Austria	13	782	540	274	167	117	26	1.2k
Marcus Bosenberg United States	13	801 1.0×	384 0.7×	322 1.2×	142 0.9×	123 1.1×	20	1.2k
Efstathia Giannopoulou Greece	20	561 0.7×	297 0.6×	277 1.0×	162 1.0×	129 1.1×	44	1.0k
JEFF EVANS United Kingdom	6	617 0.8×	397 0.7×	278 1.0×	272 1.6×	98 0.8×	24	1.2k
Nino Keshelava United States	19	914 1.2×	454 0.8×	293 1.1×	96 0.6×	120 1.0×	33	1.4k
Nathan G. Dolloff United States	19	877 1.1×	515 1.0×	296 1.1×	121 0.7×	148 1.3×	41	1.4k
Steven N. Quayle United States	17	1.0k 1.3×	557 1.0×	300 1.1×	114 0.7×	224 1.9×	37	1.5k
Meagan B. Ryan United States	11	816 1.0×	432 0.8×	177 0.6×	98 0.6×	169 1.4×	17	1.1k
Meghna Das Thakur United States	14	820 1.0×	580 1.1×	260 0.9×	288 1.7×	234 2.0×	28	1.3k
Barbara Nicke Germany	14	1.1k 1.5×	397 0.7×	212 0.8×	293 1.8×	131 1.1×	24	1.5k
Steven A. Enkemann United States	18	783 1.0×	414 0.8×	246 0.9×	100 0.6×	121 1.0×	31	1.3k

Countries citing papers authored by Andreas Wernitznig

Since Specialization

Citations

This map shows the geographic impact of Andreas Wernitznig's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andreas Wernitznig with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andreas Wernitznig more than expected).

Fields of papers citing papers by Andreas Wernitznig

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andreas Wernitznig. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andreas Wernitznig. The network helps show where Andreas Wernitznig may publish in the future.

Co-authorship network of co-authors of Andreas Wernitznig

This figure shows the co-authorship network connecting the top 25 collaborators of Andreas Wernitznig. A scholar is included among the top collaborators of Andreas Wernitznig based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andreas Wernitznig. Andreas Wernitznig is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Meier, Samuel M., Klaudia Cseh, Sarah Theiner, et al.. (2020). Plecstatin-1 induces an immunogenic cell death signature in colorectal tumour spheroids. Metallomics. 12(12). 2121–2133. 38 indexed citations

García‐Martínez, Juan Manuel, Shirley Wang, Andreas Wernitznig, et al.. (2020). Selective Tumor Cell Apoptosis and Tumor Regression in CDH17-Positive Colorectal Cancer Models using BI 905711, a Novel Liver-Sparing TRAILR2 Agonist. Molecular Cancer Therapeutics. 20(1). 96–108. 23 indexed citations

Wernitznig, Andreas, Jesse Lipp, Thomas Zichner, et al.. (2020). Abstract 3227: CLIFF, a bioinformatics software tool to explore molecular differences between two sets of cancer cell lines. Cancer Research. 80(16_Supplement). 3227–3227. 2 indexed citations

Streit, Marc, Samuel Gratzl, Holger Stitz, et al.. (2019). Ordino: a visual cancer analysis tool for ranking and exploring genes, cell lines and tissue samples. Bioinformatics. 35(17). 3140–3142. 8 indexed citations

Kiakos, Konstantinos, Giorgia Del Favero, Nathalie Harrer, et al.. (2019). First-in-class ruthenium anticancer drug (KP1339/IT-139) induces an immunogenic cell death signature in colorectal spheroids in vitro. Metallomics. 11(6). 1044–1048. 115 indexed citations

Lieb, Simone, Katharina Ehrenhöfer-Wölfer, Andreas Schlattl, et al.. (2019). Werner syndrome helicase is a selective vulnerability of microsatellite instability-high tumor cells. eLife. 8. 91 indexed citations

Zichner, Thomas, et al.. (2019). TourDino: A Support View for Confirming Patterns in Tabular Data. Eurographics. 7–11. 4 indexed citations

Zoranovic, Tamara, Jan Manent, Lee Willoughby, et al.. (2018). A genome-wide Drosophila epithelial tumorigenesis screen identifies Tetraspanin 29Fb as an evolutionarily conserved suppressor of Ras-driven cancer. PLoS Genetics. 14(10). e1007688–e1007688. 8 indexed citations

Rudolph, Dorothea, Andreas Gollner, Sophia M. Blake, et al.. (2018). Abstract 4868: BI 907828: A novel, potent MDM2 inhibitor that is suitable for high-dose intermittent schedules. Cancer Research. 78(13_Supplement). 4868–4868. 4 indexed citations

10.

Rinnenthal, Joerg, Dorothea Rudolph, Sophia M. Blake, et al.. (2018). Abstract 4865: BI 907828: A highly potent MDM2 inhibitor with low human dose estimation, designed for high-dose intermittent schedules in the clinic. Cancer Research. 78(13_Supplement). 4865–4865. 12 indexed citations

11.

Sanderson, Michael P., Marco H. Hofmann, Pilar Garin‐Chesa, et al.. (2017). The IGF1R/INSR Inhibitor BI 885578 Selectively Inhibits Growth of IGF2-Overexpressing Colorectal Cancer Tumors and Potentiates the Efficacy of Anti-VEGF Therapy. Molecular Cancer Therapeutics. 16(10). 2223–2233. 22 indexed citations

12.

Unger, Christine, Nina Kramer, Daniela Unterleuthner, et al.. (2017). Stromal-derived IGF2 promotes colon cancer progression via paracrine and autocrine mechanisms. Oncogene. 36(38). 5341–5355. 61 indexed citations

13.

Reschke, Markus, Ulrich Reiser, Dirk Scharn, et al.. (2017). Abstract 2330: BI5: a novel SMAC mimetic that triggers tumor cell death and potentiates PD-1 mediated cancer therapy. Cancer Research. 77(13_Supplement). 2330–2330.

14.

Rudisch, Albin, Nina Kramer, Nathalie Harrer, et al.. (2015). High EMT Signature Score of Invasive Non-Small Cell Lung Cancer (NSCLC) Cells Correlates with NFκB Driven Colony-Stimulating Factor 2 (CSF2/GM-CSF) Secretion by Neighboring Stromal Fibroblasts. PLoS ONE. 10(4). e0124283–e0124283. 37 indexed citations

15.

Rudolph, Dorothea, Claudia Blaukopf, Christoph Sommer, et al.. (2015). Efficacy and Mechanism of Action of Volasertib, a Potent and Selective Inhibitor of Polo-Like Kinases, in Preclinical Models of Acute Myeloid Leukemia. Journal of Pharmacology and Experimental Therapeutics. 352(3). 579–589. 50 indexed citations

16.

Glatt, Sebastian, et al.. (2008). hGPR87 contributes to viability of human tumor cells. International Journal of Cancer. 122(9). 2008–2016. 39 indexed citations

17.

Aigner, Karl Reinhard, Brigitta Dampier, Mario Mikula, et al.. (2007). The transcription factor ZEB1 (δEF1) promotes tumour cell dedifferentiation by repressing master regulators of epithelial polarity. Oncogene. 26(49). 6979–6988. 492 indexed citations

18.

Mikula, Mario, Aneesa Sultan, Brigitta Dampier, et al.. (2007). The transcription factor ZEB1 (δEF1) represses Plakophilin 3 during human cancer progression. FEBS Letters. 581(8). 1617–1624. 80 indexed citations

19.

Mikula, Mario, Aneesa Sultan, Brigitta Dampier, et al.. (2007). The transcription factor ZEB1 (deltaEF1) represses Plakophilin 3 during human cancer progression. VUBIR (Vrije Universiteit Brussel). 581(8). 1617–1624. 41 indexed citations

20.

Weber, Viktoria, Andreas Wernitznig, Gudrun Hager, et al.. (1997). Purification and Nucleic‐Acid‐Binding Properties of a Saccharomyces Cerevisiae Protein Involved in the Control of Ploidy. European Journal of Biochemistry. 249(1). 309–317. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact